z-logo
open-access-imgOpen Access
The case of histiocytosis X (Hand - Schüller – Christian disease) with thyroid gland lesion
Author(s) -
M. E. Bronstein,
Г. А. Мельниченко,
А И Бухман,
T. A. Starostina,
Olivera Ivanov,
Vyacheslav Pronin,
М Г Павлова,
A. N. Oranskaya
Publication year - 1996
Publication title -
problemy èndokrinologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 5
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl12040
Subject(s) - histiocyte , pathology , eosinophilic granuloma , histiocytosis , eosinophilic , thyroid , disease , malignant histiocytosis , langerhans cell histiocytosis , biology , medicine , endocrinology
Histiocytosis X, which is a rare disease, combines 3 related but different in clinical manifestation, course and prognosis of the syndrome: eosinophilic granuloma (Taratynovs disease), Hand Schller Christian disease (syndrome) and Letterer Siw disease (syndrome). The clinical picture of Hend Schller Christian disease was first described by Hand in 1893, then by Schller in 1915 and Christian in 1920. The term histiocytosis X was first proposed in 1953 by Liechtenstein, who combined all 3 of the aforementioned diseases under this name. on the basis of the similarity of the clinical picture, the possibility of a mutual transition from one state to another and typical morphological manifestations consisting in the proliferation of histiocytes and the accumulation of various lipids in their cytoplasm. In 1965, this concept was confirmed in all three diseases, there are no special pentalaminar markers in the cytoplasm of histiocytes that are detected in Langerhans cells (hence the name of these inclusions - "Langerhans cell granules"), the origin and biological significance of which remains unclear. Histiocytes have no signs of atypia, although they infiltrate many organs and tissues retain their normal properties. Histiocytic proliferation can develop in various organs and tissues, causing them to corresponding functional and morphological changes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here